Safety and effectiveness of mycophenolate in systemic sclerosis. A systematic review.

<h4>Background</h4>Mycophenolate is increasingly being used in the rheumatic diseases. Its main adverse effects are gastrointestinal, myelosuppression, and infection. These may limit use in systemic sclerosis (SSc) since gastrointestinal involvement is common. The objective of this study...

Full description

Bibliographic Details

Published in:	PLoS ONE
Main Authors:	Mohammed A Omair, Abdulaziz Alahmadi, Sindhu R Johnson
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Online Access:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0124205&type=printable